Trials / Completed
CompletedNCT04193085
Wearable Technology to Assess Gait Function in SMA and DMD
Wearable Technology to Assess Gait Function in Spinal Muscle Atrophy and Duchenne Muscular Dystrophy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Columbia University · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.
Detailed description
Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are genetic disorders that often result in progressive weakness and impaired function. Results from this study will help characterize how gait is affected in SMA and DMD. This novel device can serve as a more affordable and versatile measurement instrument for neuromuscular disorders that affect gait and balance. All participants will be observed and measured while wearing the instrumented insoles in the lab and in real-life environments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational | Observational |
Timeline
- Start date
- 2019-11-25
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2019-12-10
- Last updated
- 2024-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04193085. Inclusion in this directory is not an endorsement.